Related Experiment Video
Updated: Aug 8, 2026

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Basal and flow-mediated nitric oxide production by atheromatous coronary arteries
D Tousoulis1, C Tentolouris, T Crake
1Cardiology Unit, Hippokration Hospital, Athens University Medical School, Greece.
Insights
Coronary artery dilation during increased heart rate relies on nitric oxide (NO). Inhibiting NO synthesis blocks this dilation in both normal and diseased human coronary arteries, confirming NO
Area of Science:
- Cardiovascular physiology
- Vascular biology
- Nitric oxide research
Background:
- Epicardial coronary arteries dilate with increased heart rate.
- The role of nitric oxide in this dilation for human coronary arteries (normal and diseased) is unclear.
Purpose of the Study:
- To investigate the effect of inhibiting nitric oxide synthesis on human epicardial coronary arteries.
- To assess the impact on coronary flow velocity during baseline and atrial pacing.
Main Methods:
- Intracoronary infusion of NG-monomethyl-L-arginine (LNMMA), a nitric oxide synthesis inhibitor.
- Quantitative angiography to measure epicardial coronary artery lumen diameter.
- Doppler catheter to measure coronary blood flow velocity during atrial pacing.
Main Results:
- Atrial pacing increased lumen diameter during saline infusion but not during LNMMA infusion.
- Coronary blood flow velocity changes with pacing were reduced when nitric oxide synthesis was inhibited.
- Nitric oxide production was present at stenosis sites but unaffected by pacing.
Conclusions:
- Epicardial coronary artery dilation due to pacing is dependent on nitric oxide.
- Nitric oxide contributes significantly to the vasomotor tone of coronary resistance vessels.
- Nitric oxide is produced in stenotic lesions, independent of pacing stimuli.
Objectives:
This study assessed the effects of inhibition of nitric oxide synthesis on epicardial human coronary arteries and on coronary flow velocity during baseline conditions and during atrial pacing.
Background:
Epicardial coronary artery dilation occurs in response to an increase in heart rate. It is not known whether the dilation of both angiographically normal and diseased epicardial coronary arteries during atrial pacing is nitric oxide dependent in humans.
Methods:
The effects of an intracoronary infusion (4 mumol/min for 8 min) of NG-monomethyl-L-arginine (LNMMA), an inhibitor of nitric oxide synthesis, was studied in 16 patients with coronary artery disease and in 6 patients with normal coronary arteriograms. In all patients atrial pacing was performed during normal saline and during LNMMA infusion. the lumen diameter of epicardial coronary arteries was assessed by quantitative angiography, and changes in blood flow velocity were measured with a Doppler catheter.
Results:
During saline infusion a significant increase in the lumen diameter of the proximal (p < 0.05) and distal (p < 0.01) segments of both normal and diseased arteries occurred during atrial pacing. No significant lumen diameter changes occurred in either group when atrial pacing was performed during LNMMA infusion. Stenosis diameter decreased during LNMMA infusion but did not change with atrial pacing either during saline infusion or during LNMMA infusion. The mean percent change in coronary blood flow with atrial pacing was less (p < 0.05) during LNMMA infusion than during saline infusion in both groups.
Conclusions:
These findings confirm that epicardial coronary artery dilation induced by pacing is nitric oxide dependent. Nitric oxide production contributes to the vasomotor tone of coronary resistance vessels. Nitric oxide is produced at the site of atheromatous stenosis but is unaffected by pacing.
Related Concept Videos
Nitric Oxide Signaling Pathway
Autoregulation of Blood Flow
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction

